PEGylated Recombinant Factor VIII Completed Phase N/A Trials for Hemophilia A

Back to PEGylated Recombinant Factor VIII
IndicationsStatusPurposePhase
CompletedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT03169972ADYNOVATE Drug Use-Results Survey
NCT04941898A Study of TAK-660 in Surgical Procedures for People With Hemophilia A.